Public Profile

Jiangxi Renhe Pharmaceuticals Limited

Jiangxi Renhe Pharmaceuticals Limited, often referred to as Renhe Pharmaceuticals, is a prominent player in the pharmaceutical industry, headquartered in Jiangxi Province, China. Established in 2001, the company has made significant strides in the development and production of a diverse range of pharmaceutical products, including traditional Chinese medicines and modern pharmaceuticals. With a strong focus on research and development, Renhe Pharmaceuticals has carved out a niche in the market by offering unique formulations that blend traditional practices with contemporary science. The company operates extensively across various regions in China, contributing to its robust market position. Notable achievements include certifications that underscore its commitment to quality and innovation, solidifying its reputation as a trusted name in the healthcare sector.

DitchCarbon Score

How does Jiangxi Renhe Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Jiangxi Renhe Pharmaceuticals Limited's score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.

6%

Let us know if this data was useful to you

Jiangxi Renhe Pharmaceuticals Limited's reported carbon emissions

Jiangxi Renhe Pharmaceuticals Limited, headquartered in China, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of concrete emissions data and commitments, it is essential to note that the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon emissions. Companies are encouraged to adopt science-based targets and engage in climate action to mitigate their environmental impact. Jiangxi Renhe Pharmaceuticals Limited may need to align with these industry standards to enhance their climate commitments in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Jiangxi Renhe Pharmaceuticals Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Jiangxi Renhe Pharmaceuticals Limited is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Jiangxi Renhe Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Biostar Pharmaceuticals, Inc.

CN
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

Han Nan Asia Pharmaceuticals Inc.

Data Unavailable
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers